CM326
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for CM326, covering 2022-03-09 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis [Phase 3]